Shaw, C. A., Essink, B., Harper, C., Mithani, R., Kapoor, A., Dhar, R., . . . Goswami, J. (2024). Safety and Immunogenicity of an mRNA-Based RSV Vaccine Including a 12-Month Booster in a Phase 1 Clinical Trial in Healthy Older Adults. The Journal of infectious diseases, 230(3), e647-e656. https://doi.org/10.1093/infdis/jiae081
Citácia podle Chicago (17th ed.)Shaw, Christine A., et al. "Safety and Immunogenicity of an MRNA-Based RSV Vaccine Including a 12-Month Booster in a Phase 1 Clinical Trial in Healthy Older Adults." The Journal of Infectious Diseases 230, no. 3 (2024): e647-e656. https://doi.org/10.1093/infdis/jiae081.
Citácia podľa MLA (8th ed.)Shaw, Christine A., et al. "Safety and Immunogenicity of an MRNA-Based RSV Vaccine Including a 12-Month Booster in a Phase 1 Clinical Trial in Healthy Older Adults." The Journal of Infectious Diseases, vol. 230, no. 3, 2024, pp. e647-e656, https://doi.org/10.1093/infdis/jiae081.